|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.35 USD | -0.06% |
|
+0.06% | +34.36% |
| 05-22 | CVC, GBL launch EUR10.7 billion bid for Italian drugmaker Recordati | RE |
| 05-11 | Catalyst Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise | MT |
| Market Cap | 3.84B 3.31B 3.05B 2.86B 5.37B 363B 5.43B 36B 14.02B 178B 14.41B 14.1B 616B | P/E Ratio 2026 * |
16.1x | P/E Ratio 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 3.84B 3.31B 3.05B 2.86B 5.37B 363B 5.43B 36B 14.02B 178B 14.41B 14.1B 616B | EV / Sales 2026 * |
6.03x | EV / Sales 2027 * | 5.35x |
| Free-Float |
94.43% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 week | +0.06% | ||
| Current month | +0.42% | ||
| 1 month | +0.42% | ||
| 3 months | +34.59% | ||
| 6 months | +29.64% | ||
| Current year | +34.36% |
| 1 week | 31.33 |  | 31.39 |
| 1 month | 31.14 | | 31.39 |
| Current year | 22.13 | | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.68 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 31/12/2023 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 31/12/2023 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 31/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick McEnany
CHM | Chairman | 78 | 31/12/2001 |
David Tierney
BRD | Director/Board Member | 62 | 30/09/2002 |
Richard Daly
BRD | Director/Board Member | 65 | 18/02/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Fiscal year | Chief Technology Officer | 3,795 | 0.0031% | ||
| 02-16 | Fiscal year | Head of Human Resources | 1,585 | 0.0013% | ||
| 01-04 | Fiscal year | Chief Executive Officer | 94,787 | 0.0771% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.06% | +0.06% | +32.49% | +157.05% | 3.84B | |
| -0.04% | -0.27% | +17.57% | -21.52% | 62.57B | |
| -3.55% | -4.21% | +52.95% | +194.81% | 57.25B | |
| +0.08% | +33.30% | +33.30% | +33.30% | 40.76B | |
| +0.68% | +8.52% | -55.52% | -61.99% | 36.28B | |
| -1.53% | -1.73% | +49.31% | -34.23% | 29.33B | |
| +6.27% | +16.17% | +113.27% | -56.93% | 20.68B | |
| -2.19% | -3.38% | +40.04% | +57.74% | 20.37B | |
| -1.29% | +4.30% | -5.33% | +125.04% | 17.17B | |
| -1.06% | -3.06% | +51.02% | +95.81% | 16.04B | |
| Average | -0.14% | +3.30% | +32.91% | +48.91% | 30.43B | |
| Weighted average by Cap. | -0.50% | +2.85% | +29.35% | +40.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 636M 548M 505M 474M 890M 60.15B 899M 5.97B 2.32B 29.46B 2.39B 2.34B 102B | 718M 619M 570M 535M 1B 67.87B 1.01B 6.73B 2.62B 33.24B 2.69B 2.64B 115B |
| Net income | 231M 199M 183M 172M 323M 21.85B 327M 2.17B 844M 10.7B 867M 849M 37.09B | 316M 273M 251M 236M 442M 29.9B 447M 2.97B 1.16B 14.64B 1.19B 1.16B 50.74B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 31.35 $ | -0.06% | 1,768,927 |
| 15/06/26 | 31.37 $ | +0.03% | 2,817,696 |
| 12/06/26 | 31.36 $ | -0.03% | 826,904 |
| 11/06/26 | 31.37 $ | +0.10% | 1,020,948 |
| 10/06/26 | 31.34 $ | 0.00% | 960,794 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions
